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In the problem of subcutaneous immunization of human individuals 
with the virus of epidemic influenza the question of what constitutes 
an effective dose of virus is of great importance.  Francis and Magill 
(1) and Stokes et al.  (2) have shown that the administration of one or 
more subcutaneous doses of active virus to human individuals elicits 
a rise in circulating antibodies, but conclusive evidence as to the de- 
gree of active immunity engendered by this procedure has not been 
obtained.  In mice it has been well recognized that  intraperitoneal 
vaccination with active virus results in a firm immunity to intranasal 
infection.  To a  lesser extent the same effect is obtained by subcu- 
taneous vaccination, and Andrewes and Smith (3) have reported that 
high concentrations of virus induce a better degree of immunity than 
low ones.  As  a  result  of subcutaneous vaccination ferrets develop 
antibodies  but  not  complete immunity to  intranasal  infection  (4), 
while intraperitoneal vaccination is  again more efficacious than the 
subcutaneous  (5).  Little attention has been paid,  however, to  the 
strength of virus used in vaccination and to the severity of the in- 
tranasai  test for immunity. 
The object of the present studies was to ascertain the relationship 
between the concentration of influenza virus used in vaccination and 
the extent of the immunity so induced.  The details of experiments 
designed for this purpose comprise the substance of this article. 
Immunity  of Mice  to  Intranasal  Infection  after  Intraperitoneal 
Vaccination wltk Graded Doses of Virus 
Experiment/.--The PR8 mouse passage strain of epidemic influenza virus (6) 
was used.  A suspension of infected mouse lung was made by grinding the lungs 
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in meat infusion broth.  Using the original weight of the material as a unit, serial 
tenfold dilutions ranging from 1 : 10 to 1 : 1 million were made. 
Seven groups of 50 mice each were selected.  The mice of one group were given 
intraperitoneally 0.5 cc. amounts of the 1:10 dilution of virus; mice of the next 
group were given 0.5 cc. amounts of the 1 : 100 dilution of virus, etc.  At weekly 
intervals the mice were reinoculated with virus in the same concentration for a 
total of three doses.  One group of mice was kept as untreated controls.  A cer- 
tain number of animals died during the course of immunization, death being due 
apparently to intercurrent bacterial infection.  1 week  after the last  intraperi- 
toneal inoculation, each mouse, including the controls, was given intranasally 0.05 
TABLE  I 
Relation of Immunizing Dosage (Intraperitoneal) to Resistance to Intranasal Infec- 
tion with 1,000 M.L.D. (Mice) 
Immunizing 
dose of virus 
10  -I  39  0 
10  -2  49  0 
10- a  50  0 
10  -4  50  1 
10  -s  50  28 
10  -s  48  47 
Tnvaccinated  49  45 
controls 
Deaths  Num- 
ber of 
Per  mice  No.  cent 
0 
0 
0 
2 
56 
98 
92 
Pulmonary. lesions 
m  survivors 
0  0  0  0  0 
0  0  0  0  0 
0  0  0  0  0 
0  0  0  0  0 
0  4-  0  4-  0 
0  0  4-  0  0 
+  0  ±  0  + 
++  0  ++  0  4- 
++  +  +  ++  ++ 
Titration  of virus used for infection 
5, 7, 7, 8, 9, 10 
8, 9, ++-k+,  ++, ++++, ++++ 
9, 10, ++++,  -4-, +++,  ++ 
4- to +  +  +  -b  =  increasing degrees of pulmonary involvement. 
0  -- no pulmonary involvement. 
Numerals in titration results indicate day of death of individual mice. 
cc. of a 1 per cent suspension of virus (approximately 1,000 lethal doses).  It should 
be noted that mouse passage virus in a dilution of 10  -5 produces fatal infection in 
the great majority of mice.  The animals were observed for 10 days, and on the 
11th day representative groups of survivors were sacrificed and the presence of 
pulmonary lesions was determined.  The results are presented in Table I. 
A  definite relationship  between  the  strength  of virus  used  for im- 
munization  and  the  resultant  degree  of  immunity  is  seen.  Mice 
vaccinated  with  virus  in  1:10  and  1:100  dilutions  were  completely 
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all the mice and the absence of pulmonary lesions.  Mice vaccinated 
with the 1:1,000 concentration of virus exhibited less complete im- 
munity in that, while all mice survived, occasional pulmonary lesions 
of minimal severity were seen.  One of the mice immunized with the 
1:10,000  concentration died and pulmonary lesions were more fre- 
quent and more extensive in the survivors.  Approximately half of 
the mice immunized with virus  diluted to  1:100,000  died and  the 
survivors uniformly showed pulmonary lesions of moderate extent. 
When given by the intranasal route virus in a  concentration of  1:1 
million proved capable of producing extensive pulmonary lesions and 
some deaths, but when given intraperitoneally it failed to elicit any 
immunity to the test dose, since mice so treated died as uniformly as 
the controls. 
Thus complete immunity to 1,000 lethal doses was observed only 
in those mice vaccinated intraperitoneally at each injection with the 
equivalent of 1,000 lethal intranasal doses or more.  Fatal infections 
developed in mice vaccinated with amounts of virus  equivalent to 
less than 100 letkal doses.  The regular gradation in immunity paral- 
leling the gradation in immunizing dose is extremely clear and indicates 
that statements regarding immunity must under these conditions be 
accompanied by quantitative data. 
The fact that complete immunity to intranasal infection with 1,000 
lethal  doses  was  acquired  only  by  mice vaccinated with  virus  of 
similar strength,  or more, suggested that  a  given amount  of virus 
injected  intraperitoneally  induces  a  degree  of  immunity  effective 
against  no more than  the equivalent strength  of virus injected in- 
tranasally.  The  following  experiment  was  devised  to  study  this 
possibility. 
Experiment 2.--The Melbourne strain of epidemic influenza virus  (7)  in its 
128th to 131st transfer in chick embryo-Tyrode's tissue culture medium was used. 
The virulence of the virus was such  that 0.05  cc. of a  1:10,000 dilution of the 
supernatant fluid given intranasally caused a fatal infection; a  1 : 100,000  dilution 
invariably caused well marked pulmonary lesions, with  occasional deaths; and 
inconstant, mild pulmonary lesions followed injection with the virus in a dilution 
of 1:1  mlton.  Groups of 50 mice each were inoculated intraperitoneally with 
0.5 cc. amounts of the undiluted culture supernatant and with similar amounts 
of the supernatant diluted 10  -1,  10  -~,  10  -8, and  10  -4, respectively.  Two injec- 
tions were given, 1 week apart.  A group of 50 untreated control mice was kept. + 
÷ 
+ 
/ 
/ 
÷ 
+  ~  ++ 
+ 
+  ++ 
+ 
.......  ++  ~++ 
-I- 
+ 
"t- 
/ 
ee~u~  e~*  .q~  .q*  u-~  ~*  ~-,.  t~.  I 
/ 
+ 
0 
+o 
÷ 
m 
~  ~0  O0  00  O0 
~  0 
t~*¢~  O0  "J~O  0¢~  0C3 
~o  +o  +o  oo  o~ 
÷ 
.,++  +o  ++÷  ~o  +o 
oo  oo  o-Jl  ,=o  o+ 
+~:oooooooo 
OQ  00  O0  O0 
~O  QO  ~0  O0  0~ 
~  O0  ~0  00  O0 
286 
0 
i~ ~ 
÷~ 
+~ THOMAS  I~RANCIS, JR.  287 
A week after the second intraperitoneal injection ten mice of each group were 
infected intranasally with 0.05 cc. of full strength culture virus; other groups of ten 
each received  0.05 co. of culture diluted 1  : 10, 1  : 100, 1  : 1,000, and 1 : 10,000, respec- 
tively.  Thus, mice vaccinated with a given concentration of virus were tested for 
immunity with graded amounts containing from 1 to 10,000 lethal doses of the 
same strain of virus.  Unvaccinated control mice were similarly infected.  The 
mice were observed for 10 days and deaths recorded.  All survivors were sacrificed 
and the degree of pulmonary involvement was noted.  It should be observed that, 
in the experiment presented, minute lesions were seen in the lungs of many of the 
surviving mice.  This may be due to the fact that only two vaccinating injections 
were given, or more probably is rdated to the use of chick embryo culture material. 
The results are presented in Table II. 
There is a  striking relationship between the strength of virus used 
for vaccination and  the dose of virus against which the mice were 
protected.  Mice  vaccinated  with  fuU  strength  virus  survived  in- 
infection with  full strength  virus.  HaLf the  mice  vaccinated with 
culture virus diluted 1:10 died when tested against full strength virus 
but were immune to the 1 : 10 and weaker dilutions of virus.  Similarly, 
mice vaccinated with the  1:100  dilution of virus were resistant  to 
infection with a  1 : 100 or higher dilution of virus, but exhibited only 
partial immunity to the 1:10 concentration and little or no immunity 
to the undiluted material.  The same sequence of events was seen in 
mice vaccinated with the 1:1,000 dilution; they exhibited an increased 
resistance to virus of the same strength as that used for vaccination 
but not against the higher concentrations.  Vaccination with a  dilu- 
tion  of  1:10,000  induced no  apparent  resistance  since  the  mice  so 
treated showed no appreciable difference from the controls in their 
reaction to infection even with virus of the same strength as that used 
in their vaccination. 
When measured by survival and death the results strongly suggest 
that,  under  the  conditions of this  experiment,  intraperitoneal vac- 
cination with a given dose of virus induces a degree of immunity sufli- 
dent to protect mice against intranasal infection with virus of equiv- 
alent strength or less.  Below a  certain level of virus concentration 
vaccination does  not  afford protection  even  against  infection with 
virus of the same concentration.  On  the other hand, in the upper 
range of immunizing doses a  firm immunity is established, effective 
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that there is a threshold of immunity which varies with, and is closely 
proportionate  to,  the  concentration of  virus  used  in  the  process  of 
immunization.  Suspensions  of  virus  containing  less  than  10  lethal 
or 100 infectious doses per 0.05 cc. produce little immunity, but above 
that  level  the  concentration  of  virus  which  mice  will  resist  is  ap- 
proximately the same as the concentration of virus used for vaccina- 
tion. 
The Relation  of Vaccinating  Dosage to the Development of Antibodies 
and Resistance to Infection in Ferrets 
Vaccination  of  ferrets  with  influenza  virus  administered  by  the 
subcutaneous route does not ordinarily result in a  complete resistance 
of the animal to intranasal infection.  That immunity is produced is 
shown,  however, by the fact  that  properly vaccinated ferrets when 
subsequently infected do not  develop the pneumonic lesions  typical 
of experimental influenza in that species of animal  (4).  Since, how- 
ever, no studies on the quantitative aspects of the problem in ferrets 
have been reported, it seemed of interest to determine what relation- 
ship, if any, exists between the size of the immunizing dose for that 
animal and the subsequent  response to infection.  The following ex- 
periments were,  therefore, undertaken. 
Experiment 3.--The PR8 ferret passage strain of epidemic influenza virus was 
used.  The lung of an infected ferret placed in glycerine 10 days previously served 
as the source of virus.  Virus  so obtained almost invariably produces  infection 
when given to normal ferrets intranasally in dilution of 10  -6 and frequently in 
lower concentration.  Using the weight of lung tissue  as the unit, a suspension 
was made by grinding with alundum, and six tenfold serial dilutions ranging from 
10  -t to 10  -6 were made in Locke's solution.  Twelve normal ferrets, previously 
bled from the heart, were selected and 4.0 cc. of the virus dilution was then given 
subcutaneously, in the flank, to each of two ferrets.  The site of the inoculation 
was then painted with alcohol and iodine and observed for leakage.  This painting 
discouraged  the animal from licking  the site of injection, a habit infrequent in 
ferrets even in the absence  of such precautions.  In this manner groups of two 
ferrets were vaccinated with the respective dilutions of virus.  Those receiving 
the lowest concentrations of virus were vaccinated first to prevent deterioration 
of the virus through standing.  In order to demonstrate the infectivity of the virus 
suspension control animals were inoculated intranasally, under ether, with 2.0 co. 
of the 10  -s dilution. 
Temperatures of the vaccinated ferrets were taken daily and the animals were 
observed for any other signs of infection.  None was detected. THOMAS FRANCIS~ JR.  289 
One week later and again 2 weeks later the same procedure was carried out, 
each time using the same glycerlnated lung as the source of material. 
Two weeks after the third weekly subcutaneous injection all animals,  while 
anesthetized with ether, were given intranasally 2.0 cc. of a 10 per cent suspension 
of freshly infected ferret lung.  Subsequently,  their  temperatures were  taken 
twice daily, their appetites noted, and records of nasal and respiratory symptoms 
made by a trained caretaker who was uninformed as to the nature of the study. 
One or two unvaccinated control animals were infected at the same time.  2 weeks 
after infection each animal was bled from the heart and the serum removed for 
antibody titrations.  The animals  were  then sacrificed in order that the lungs 
might be examined for pneumonic lesions. 
Antibody titrations of each serum were made in mice by the method described 
by Francis and Magill (8) in which  serial  dilutions of serum are tested against 
1,000 lethal doses of mouse lung suspension of the PR8 strain of virus.  The mice 
are observed for 10 days and the dilution of serum which protects 50 per cent 
of the mice from fatal infection is taken as the end-point. 
The results of the clinical, serological, and pathological observations 
are summarized in  Table III.  Antibodies were not detected in the 
serum  of animals  vaccinated  with  the  10  --6 or  10  --5 concentration  of 
virus,  in one of the two vaccinated with the  10-  4 concentration, but 
were present in the serum of all those receiving the 10  003, 10-  ~, or 1000  1 
concentrations.  Hence  antibodies  were  detected  only in  those  ani- 
mals vaccinated with concentrations of virus which were equivalent 
to 100 or more infectious doses.  Complete immunity as measured by 
absence of fever and clinical symptoms was not produced even in the 
presence of antibodies.  Nevertheless, the ferrets which had received 
the  largest  vaccinating  doses  of virus  presented  the  most  modified 
reactions in  the  immunity  test.  Their fever was  mild  and  of brief 
duration; in the first four animals a  single rise of temperature to the 
upper limit of normal was observed.  Nasal symptoms were slight or 
absent, and no respiratory distress was detected.  Animals vaccinated 
with the 1 : 100 dilution presented higher fever of longer duration be- 
ginning earlier after infection.  Furthermore, mild respiratory symp- 
toms were noted.  In animals vaccinated with smaller doses the febrile 
course  was  more  prolonged;  both  nasal  and  pulmonary  symptoms 
became  progressively  more  marked  so  as  to  approach  the  type  of 
disease noted in the control animals.  When  the animals were sacri- 
ficed 2 weeks after infection, it was found that those vaccinated with 
the smaller doses presented characteristic pneumonic lesions in their 
lungs,  whereas  those  which had  received the larger doses  had  been 290  IMMUNITY  TO  INFLUENZA  VIRUS 
TABLE  m 
Relation  between Vaccinating  Dose and  Resistance  to  100,000 Infectious  Units in 
Ferrets 
Ferret 
No. 
6-94 
6-95 
6-96 
6-97 
6-98 
6-99 
7-00 
7-01 
7-02 
7-03 
7-04 
7-05 
7-06 
7-07 
& 
'accinatlng  til 
dose  v 
10-  i 
10-2 
lO-2 
lO  -3  i 
lO-3 
lO-4 
lO-4 
10-  ~ 
10-6 
10-  e 
Control 
Control 
fib My 
er .a !ter 
~ecl]  ta~ 
tioJ 
10( 
33.  t 
15( 
16~ 
I6~ 
10( 
0 
2.  t 
0 
0 
0 
0 
Response to intranasal infection 
Fever  Signs 
Highest I  Duration 
oF.  I  hrs. 
104.0  12 
103.6  12 
104.0  8 
104.1  8 
105.1  24 
48 
48* 
48* 
48* 
1.,05.9  72 
105.7  144 
216t 
48* 
Nasal  1Pulmonary 
±  0 
0  0 
+  o 
4-  0 
+  + 
105.3 
104.2 
105.7 
106.7 
107.2 
105.0 
105.9  Moribund 
4th day 
-4- 
+ 
+ 
++ 
++ 
++ 
+++ 
+ 
0 
-4- 
++ 
+++ 
+++ 
+++ 
++ 
++++ 
Antibody 
Lung lesions  titer 
2 wks. later  after 
infection 
0  3,200 
0  3,200 
0  1,600 
0  1,140 
0  1,140 
0  3,200 
+  280 
d:  1,200 
++  140 
+++  IOO 
+  280 
+++  96o 
Sacrificed 
4th day 
+++ 
++++ 
In Tables III and IV. 
Nasal 
=t=  =  slight nasal discharge, 1 day. 
-t-  =  discharge definite, 1 day. 
+  +  =  dirty  nasal  discharge,  2  to 
3 days, 
+ + +  =  dirty nasal discharge, 3  to 
5 days. 
+ + + +  =  dirty nasal discharge,  5  or 
more days. 
Pulmonary 
Respirations irregular. 
Respirations increased,  1 to 2 days. 
Respirations increased, 3 to 6 days. 
Respirations labored, 2  to 5 days. 
Respirations labored, 5 to 7  days. 
* Subsequent secondary rise of temperature. 
t  Temperature  subnormal,  first 3  days. 
protected  from  pulmonary  consolidation.  The  pulmonary  lesions 
were first detected  in the ferrets receiving the  10  -~ vaccinating dose, 
which was also the critical level for antibody formation. THOMAS FRANCIS, JR.  291 
It  appears,  therefore,  that  the  concentration  of virus  in  the  im- 
munizing dose exerts a distinct influence upon the degree of immunity 
which is evoked and upon the production of antibodies.  Immunizing 
doses of virus equivalent  to  100  intranasal  infectious doses or more 
appear  to  elicit  evidence  of  immunity,  while  smaller  doses  fail  to 
induce  antibody  formation,  to  influence  the  severity  of  the  clinical 
disease, or to protect ferrets from pulmonary involvement when they 
are tested for immunity with approximately  100,000 infectious doses 
of virus. 
Experiment 4.--The same procedure as that  of Experiment  3 was repeated, 
except that the vaccinating material was produced from a freshly infected ferret 
each week in place of stock glycerinated virus.  A 1 per cent suspension of virus 
was used in the immunity test instead of a 10 per cent suspension, as in Experi- 
ment 3.  Furthermore,  the animals were not sacrificed for pathological sections 
after the immunity test.  Control animals were inoculated intranasally  with the 
10  -6 preparation  of virus each week at the time of vaccination.  In one of the 
three instances virus was not demonstrable at that dilution, hence ferrets vac- 
cinated with the 10  -6 dilution of virus received only two injections of virus. 
Table IV presents the tabulated data. 
The results of the experiment were closely similar  to those of Ex- 
periment  3.  Antibodies  were not  detectable in  animals  vaccinated 
with doses containing  less than  100 intranasal  infectious units  (10  -5, 
10-6).  In general the temperature reaction was more marked than in 
the  previous  experiment  although  ferret  10-51  showed  almost  no 
clinical  evidence  of  infection  and  ferret  10-50  had  only  borderline 
fever.  The  animals  which  developed  no  demonstrable  antibodies 
exhibited a  much more severe type of infection than  those in whose 
serum antibodies had  developed.  The  animals  receiving the largest 
vaccinating doses (10  -1, 10-  ~) had somewhat higher titers of antibodies 
and  less  prolonged  febrile reactions  than  those  receiving the inter- 
mediate sized doses (10-  3  ,  10-4).  Additional  evidence of response to 
the virus administered  intranasally  was obtained,  both in these ani- 
mals and those of Experiment 3, in that all ferrets possessing circulat- 
ing antibodies  developed a  further marked  increase in  antibodies as 
a result of the immunity test, and the level attained was much higher 
than  that  observed in  the  ferrets  which  showed no  antibodies  as  a 292  IMMUNITY  TO  INFLUENZA  VIRUS 
result  of  vaccination.  This  phenomenon  is  not  observed  in  fully 
immune animals  and is interpreted  as  evidence of modified suscep- 
tibility. 
The  Relation  of Infecting  Dose  of  Virus  to  Severity  of Disease  and 
Immunity 
The previous evidence of a  marked quantitative  relationship be- 
tween the size of the virus dosage and  the resultant  immunity was 
TABLE  IV 
Relation  between Vaccinating Dose and  Resistance to  10,000 Infectious  Units  in 
Ferrets 
Ferret No. 
10-54 
10-53 
10-52 
10-51 
10-50 
10-49 
10-48 
10-47 
10-46 
10-45 
10-44 
10-43 
9-83 
'accinatin~ 
dose 
10-1 
10-1 
10-  2 
10-  2 
10-  8 
10--3 
lO-~ 
10--4 
lO  ~ 
lO-5 
10-  s 
10-  8 
Control 
An :ih 
tit¢ r 
race Lm 
~0 
L4 
,0 
:0 
2, 
ty 
er 
[on 
Response to intranasal infection 
Fever 
Highest  Duration 
hrs. 
104.7  24 
104.8  12 
105.4  24 
None 
103.2  48 
103.5 
106.2  24* 
104.4  72* 
105.9  48* 
104.6  96~ 
104.1  120 
106.0  72~ 
104.6  48* 
106.3  72* 
Signs 
Nasal  flmon~ 
0  0 
±  0 
+  ± 
±  0 
++  + 
+  o 
± 
++++  ~+0  + 
++++  ++ 
Antibody 
titer after 
infection 
3,000 
2,250 
960 
1,350 
960 
1,140 
1,140 
1,140 
565 
565 
4OO 
4OO 
Not  done 
J~ Temperature dropped to subnormal level. 
based upon intraperitoneal  or subcutaneous vaccination of  animals. 
It seemed of interest, therefore, to compare the effects when similar 
quantitative  experiments were performed with different amounts of 
virus given intranasally  so as to produce infection.  The character- 
istics of the resultant disease could be studied clinically and the degree 
of immunity produced by graded infectious doses of virus could be 
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Experiment 5.--A group of twelve ferrets (Nos. 6.44 to 6-55) was divided into 
six groups of two each.  Serum  was obtained from each animal by cardiac punc- 
ture.  A suspension of the lungs of a ferret infected with the PR8 strain of epi- 
demic influenza virus was prepared, and serial tenfold dilutions of virus, 10  -1 to 
10  -6, were made.  A pair of ferrets while  anesthetized were inoculated intranasaUy 
with 2.0 cc. of a given virus dilution.  Temperatures were taken twice daily and 
all symptoms were recorded.  14 days after infection samples of serum were again 
obtained, and in order to test for immunity aU animals were reinoculated intra- 
nasaUy I week  later with 2.0 cc. of a 10 per cent suspension of ferret passage virus. 
14 days after the immunity test serum was again obtained.  Titrations  of the 
neutralizing antibody content of each serum were done in mice, with 1,000 lethal 
doses of the PR8 mouse  passage strain of virus as a standard concentration. 
A marked difference in the severity of infection resulting from differ- 
ent infectious doses was seen.  The larger doses produced a marked, 
sustained fever, loss of appetite, severe respiratory distress, and pro- 
fuse nasal discharge.  With the smaller doses the incubation period 
was prolonged and the disease, in general, was much milder.  In two 
ferrets,  one  receiving  the  10  -5  dilution  and  one  receiving  the  10  "~ 
dilution, extremely mild infection resulted.  In each instance a  brief 
rise of temperature was detected on the 5th day although few clinical 
signs  of  infection were  observed.  When  the  series  of  ferrets  was 
tested for immunity on the 21st  day after the original inoculation, 
all were immune as shown by the lack of fever or other evidence of 
illness.  All animals had developed  antibodies of  similar titer  as  a 
result of the primary infection, except the two ferrets mentioned above 
whose titers were lower.  In response to reinoculation only these two 
animals showed additional rise in antibody titer, indicating that de- 
spite the absence of clinical response to infection, they had not reached 
as complete a state of immunity  as the others which seemed completely 
refractory.  The evidence suggests, then, that with the possible ex- 
ception of  two  animals exhibiting the  slightest  degree  of infection, 
the immunity present  immediately after infection bears  no relation 
to the size of the infectious dose and that fully immune animals when 
reinoculated  do  not  respond  with  additional  antibody  formation. 
It was  conceivable, however, that, were the interval between the 
primary and  secondary infections prolonged  until  some  of  the  im- 
munity was lost, a correlation between the size of the original infecting 
dose and the degree of immunity which persisted could be had.  Ac- 
cordingly, the experiment was repeated. 294  IMMUNITY  TO  INFLUENZA  VIRUS 
Experiment 6.--Ferrets were infected in the same manner as in Experiment 5. 
Those which received the largest dose succumbed to a severe infection.  Both 
ferrets receiving the smallest dose, 10  -6, developed fever on the 7th day after 
inoculation and exhibited minimal signs of disease.  There was a distinct tendency 
to gradation of symptoms with infectious doses of the intermediate size.  14 and 
93 days after the first inoculation the animals were bled.  On the 98th day all 
ferrets were reinoculated intranasally with 2.0 cc. of a 10 per cent virus suspension, 
two normal controls receiving the same dosage.  The course of the reaction to the 
second dose of virus was again recorded and a third  bleeding obtained  10 days 
after reinoculation.  Antibody titrations  were performed as previously described 
The results of the study in half the series are presented graphically 
in Chart  1.  In each instance the ferret represented is the second ani- 
mal of the pair.  The sequence of events in the group comprising the 
alternates was similar but somewhat obscured by the fact that  three 
of those animals developed secondary complications late in the disease. 
It  can be seen that  the  animals  which developed the most  severe 
illness  as  a  result  of the  original  infection  were those  receiving  the 
larger doses.  When tested 3 months later with a large concentration 
of the  same virus,  the  animals  which  originally  developed the  least 
severe  (in  No.  6-79 practically  subclinical)  infection  appeared  to be 
most  severely affected,  while  those  which  had  undergone  the  most 
marked  primary  infection  appeared  to be the  most  resistant  to the 
second inoculation  of virus.  The level of antibodies in  the interval 
between tests had tended to decline although in No. 6-79 a pronounced 
increase was observed.  This may be due to the fact that the interval 
between the onset of the first infection and the time of bleeding was 
relatively shorter than  in  the other ferrets.  The mate of No.  6-79, 
however, had a  relatively low antibody titer throughout. 
The  evidence,  then,  suggests that  with  the  passage  of time there 
may be a relationship between the size of the infecting dose, the sever- 
ity of  the  disease,  and  the  relative  resistance  to  infection  after  the 
period of firm immunity has passed.  In this connection it should be 
noted that,  compared with the previously untreated  control animals. 
the disease resulting from reinoculation of the partially immune ferrets 
was  distinctly  modified.  Moreover,  in  response  to  the  second  in- 
fection the antibody development was strikingly accelerated, reaching 
in  almost  every instance  the  limit  of  titer,  1:3,200.  This  type  of 
serological  response  characterizes  the  partially  immune  animal,  as THOMAS  I~RANCIS~  JR.  295 
shown  by comparison with the titers in the same animals after the 
first infection.  As described in Experiment 5,  the fully immune ani- 
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mal ordinarily shows little  or no serological  response to the second 
stimulus.  In fact, evidence is at hand which suggests that the anti- 296  IMMUNITY  TO  IN"FLUENZA  VIRUS 
body response to second inoculation is inversely proportionate to the 
degree of immunity. 
DISCUSSION 
The results of experiments dealing with the immunization of mice 
with epidemic influenza virus injected by  the intraperitoneal route 
seem clearly to establish a quantitative relationship between the con- 
centration of virus in the immunizing dose and the level of immunity 
which is reached.  Thus it was found that a  progressive increase in 
the virus concentration of the immunizing dose was paralleled by a 
similarly increasing degree of immunity as measured by infection with 
1,000 intranasal lethal doses of the same virus.  Complete immunity 
to this infecting dose was demonstrable only in mice vaccinated with 
concentrations  of  virus  containing  approximately  1,000  intranasal 
lethal  doses, or more, per 0.05  cc.  Vaccination with  smaller doses 
resulted in decreasingly effective immunity until the vaccinating range 
of  approximately one lethal  dose per injection was  reached,  when 
no evidence of immunity was observed. 
Subsequently,  mice  vaccinated with  serially  decreasing doses  of 
virus were tested with a  parallel range of infectious doses.  In this 
instance the correlation between the concentration of virus used for 
vaccination and the concentration of virus which the animals could 
overcome is remarkable.  In fact, it appears to be a direct proportion. 
Mice vaccinated with a  given concentration of virus are  protected 
against infection with virus in approximately the same concentration 
or less, but are either not protected or only partially protected against 
larger concentrations of virus.  With  the smallest vaccinating doses, 
approaching the range of one lethal intranasal unit per 0.05  cc.,  no 
detectable immunity is produced even against the equivalent concen- 
tration of virus.  Thus there appears to be an irreducible minimum of 
approximately ten intranasal lethal doses required for the induction 
of even the mildest degree of immunity, and there is a definite thresh- 
old to the level of immunity which  a  given  concentration of  virus 
can elicit.  The threshold of resistance corresponds in general with 
the concentration of virus used in vaccination. 
In ferrets, while complete immunity is not obtained as a  result of 
subcutaneous  vaccination  with  active  virus,  a  distinct  resistance 
develops.  When  vaccinated  ferrets  are  tested  intranasaUy  with THOMAS ]~RANCIS, JR.  297 
10,000  to  100,000  infectious units, the resultant clinical response is 
clearly conditioned by the concentration of virus used in vaccination. 
This is further shown by determination of the antibody production 
after vaccination.  Antibodies are not produced until the concentra- 
tion of virus in the immunizing dose reaches 100 infectious units, an 
amount  corresponding roughly with the  minimal  requirements  for 
the development of effective immunity in mice.  The animals at the 
borderline are somewhat more severely affected than those immunized 
with the higher concentrations, but the state of partial immunity and 
antibodies appear uniformly together. 
The observations reported are somewhat similar to those of Olitsky 
and Cox  (9-11)  with the virus of equine encephalomyelitis.  These 
authors noted that approximately 1,000 mouse lethal units of virus 
were required to induce immunity in guinea pigs by the subcutaneous 
route,  even though fatal  infection frequently occurred when larger 
immunizing doses were used.  In mice the equivalent of 1,000 lethal 
units in formolized vaccine was required to give immunity to 20  to 
50 intracerebral lethal doses,  and when no immunity developed no 
demonstrable antibodies were present in the blood.  Study of their 
protocols suggests that a still closer proportionate relationship, some- 
what similar to that of Experiment 2 of the present series, actually 
existed. 
The  results  of  the  vaccination  experiments in  which  a  definite, 
proportionate relationship between size of the immunizing dose and 
immunity is found to exist are in sharp contrast to those obtained as 
a result of infection.  Infection is followed by a staunch immunity to 
reinfection even though the infectious dose is so small as to elicit little 
more than a  subclinical infection.  The severity of the disease tends 
to vary with the infecting dose, but,  in general, the immediate im- 
munity is related to infection and not to the amount of virus inocu- 
lated.  In certain instances, after infection with the smallest doses, 
reinoculation results in a  second rise of antibody titer although the 
animal is clinically immune.  Moreover, when an interval of months 
elapsed between the first and second tests, the impression was gained 
that animals receiving originally the largest doses and exhibiting the 
most severe infections presented the mlldest reactions to reinoculation, 
whereas  ferrets  which  experienced the  mildest  infection  originally 298  IMMUNITY  TO  INFLUENZA  VIRUS 
tended to have the most marked reactions to reinoculation.  Never- 
theless~ all animals retained a distinct but modified state of immunity. 
It becomes obvious that the action of the virus in inducing immunity 
following  vaccination  differs  from  that  in  play  during  infection. 
Introduction of minute amounts of virus by the intranasai route results 
in infection~  multiplication of the virus,  and  a  staunch, immediate 
immunity essentially unrelated to the amount of virus  introduced. 
By the intraperitoneal route in mice, or by the subcutaneous route 
in ferrets, it is necessary to inject virus in a concentration of ten fatal 
intranasal units for mice or 100 infectious units in ferrets before eUcit- 
Lug any  evidence of  immunity.  Mice  receiving less  than  subfatal 
doses intranasally become solidly immune and a single infectious unit 
in the ferret intranasally is followed by complete resistance to rein- 
fection.  Since relatively large amounts of virus as measured by  in- 
fectious capacity are required to induce any degree of immunity by 
vaccination, and since there is  such a  relatively sharp limit to  the 
amount of immunity any given effective dose can create,  there can 
be little appreciable multiplication of virus or multiplication in such 
limited extent as to maintain a strict proportion with the amount of 
virus  injected.  This  is  especially  striking  since  multiple  doses  of 
virus were used in  vaccination and  the length of time over which 
each experiment was carried was sufficient to permit the development 
of any effects which virus multiplication might produce. 
From the point of view of vaccination of human individuals with 
active virus, the criticism that the procedure might induce infection 
seems, on the basis of the present results, not to be sound since, with 
infection,  multiplication of  virus  ordinarily  ensues.  Moreover,  in 
ferrets the immunity induced by minimal intranasal infection is far 
superior to that produced by maximal vaccinating doses.  The results 
also tend to  answer in  the negative the question previously raised 
(12) as to whether virus which reaches the lung after intraperitoncal 
inoculation  actually  multiplies.  It  is  not  necessary  for  virus  in 
demonstrable amounts to  reach  the  lung  from  the  peritoneum  in 
order that immunity may develop, nor apparently does multiplication 
of virus occur in the development of immunity following vaccination. 
The even gradations in immunity militate against the possibility of 
virus multiplication. 
Another observation reported in this communication deserves coin- THOMAS ]~EANCIS, JR.  299 
ment.  It has been uniformly found in ferrets vaccinated subcutane- 
ously with influenza virus that with adequate doses a state of partial 
immunity is produced and circulating neutralizing antibodies can be 
detected.  When subjected to intranasal inoculation with virus these 
ferrets exhibit definite evidence of infection, but the disease is clearly 
of a  modified type.  Subsequently a  marked secondary Hse of anti- 
bodies occurs, greatly exceeding the level reached in animals infected 
without  previous  treatment.  The  same  phenomenon is  observed 
when ferrets  previously infected are  reinoculated intranasally  after 
an interval of months, when sufficient immunity has been lost to per- 
mit of  clinical reaction  to  reinfection  (Chart  1).  This  accelerated 
serological response appears, therefore, to typify the reaction of the 
partially  immune animal to  reinfection.  In  the  human individual 
it has been noted that as a result of infection a certain proportion of 
affected subjects develop much higher  antibody  titers  than  others 
(8).  It may be that in these instances the accentuated serological 
response characterizes the individual in a  state of partial immunity, 
whereas  the  mild  rises  in  titer  observed in  individuals previously 
possessing no antibody indicate that they may be undergoing their 
first infection with epidemic influenza virus. 
SUMMARY AND  CONCLUSIONS 
A  direct proportion exists between the concentration of epidemic 
influenza virus used for intrapeHtoneal immunization of mice and the 
degree  of  immunity to  intranasal  infection which develops.  Mice 
vaccinated with virus of a  given strength resist infection with virus 
of the same concentration but not more.  An irreducible minimum 
exists since mice vaccinated with less than ten intranasal lethal doses 
do not develop sufficient immunity to overcome intranasal infection 
with virus of the same strength.  The fact that there exists a limit- 
ing threshold for the degree of immunity which a  certain strength of 
virus  will  induce indicates  that  the  virus  does  not  multiply after 
intraperitoneal inoculations. 
In ferrets a state of partial immunity is induced as a result of sub- 
cutaneous vaccination with active influenza virus.  Vaccination with 
doses containing 100 or more intranasal infectious units is required 
for the production of circulating antibodies, protection of the animals 300  IMMUNITY TO  INFLUENZA VIRUS 
from pulmonary involvement, and modification of the severity of the 
disease.  On the other hand, intranasal inoculation with one infectious 
unit results in a firm, immediate immunity, although the duration of 
immunity may bear a relation to the severity of the original infection 
and consequently to the size of the infecting dose. 
Ferrets in a state of partial immunity resulting from subcutaneous 
vaccination, or from the waning of a  firm immunity following infec- 
tion, respond to intranasal inoculation of influenza virus with an ac- 
celerated production of neutralizing antibodies.  The antibody titer 
under these conditions reaches a  much higher level than occurs fol- 
lowing a  primary infection.  Fully immune animals, however, show 
no further antibody response to a second inoculation. 
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